Key Events This Week
23 Feb: Stock opens at Rs.181.70, down 0.41% despite Sensex gain
24 Feb: New 52-week low of Rs.177.35 amid continued downtrend
25 Feb: Further decline to 52-week low of Rs.175.40
26 Feb: Intraday high of Rs.190.8 with 7.33% surge, short-lived rebound
27 Feb: Sharp fall to new 52-week low of Rs.173.6, closing at Rs.175.05
23 February 2026: Week Opens with Mild Decline Amid Sensex Gains
Dishman Carbogen Amcis Ltd began the week at Rs.181.70, down 0.41% from the previous close, despite the Sensex rising 0.39% to 36,817.86. The stock’s modest decline on a day of broader market strength foreshadowed the challenges ahead. Trading volume was moderate at 14,259 shares, indicating cautious investor participation.
24 February 2026: Shares Hit 52-Week Low as Downtrend Deepens
The stock fell sharply to a fresh 52-week low of Rs.177.35 intraday, closing at Rs.179.50, down 1.21%. This marked the fourth consecutive session of losses, cumulatively an 8.99% drop over that period. The decline occurred amid a broader market sell-off, with the Sensex falling 0.78% to 36,530.09. Dishman Carbogen Amcis Ltd underperformed its Pharmaceuticals & Biotechnology sector, which declined less steeply. Technical indicators showed the stock trading below all major moving averages, signalling sustained bearish momentum.
25 February 2026: Further Slide to New 52-Week Low Despite Sensex Recovery
The downward pressure continued as the stock touched an intraday low of Rs.175.40, closing at Rs.176.65, down 1.59%. This fifth consecutive day of losses brought the cumulative decline to 11.41%. Notably, the Sensex rebounded 0.41% to 36,679.75, highlighting the stock’s relative weakness. The Pharmaceuticals & Biotechnology sector outperformed Dishman Carbogen Amcis Ltd by 3.55% on this day. The company’s fundamentals remained under scrutiny, with a low Return on Capital Employed (ROCE) of 0.97% and high leverage ratios contributing to investor caution.
Turnaround taking shape! This Small Cap from NBFC sector just hit profitability with strong business fundamentals showing up. Catch it before the major breakout happens!
- - Recently turned profitable
- - Strong business fundamentals
- - Pre-breakout opportunity
26 February 2026: Sharp Intraday Rally Breaks Losing Streak
After five days of declines, Dishman Carbogen Amcis Ltd staged a notable intraday recovery, surging 7.33% to close at Rs.185.00. The stock reached an intraday high of Rs.190.80, an 8.01% increase from the previous close. This rebound outperformed the Pharmaceuticals & Biotechnology sector by 6.84%, while the Sensex marginally declined 0.12%. The stock traded above its 5-day moving average, indicating short-term buying interest, though it remained below longer-term averages. Despite this bounce, the company’s Mojo Score remained at a low 17.0 with a Strong Sell rating, reflecting ongoing fundamental concerns.
27 February 2026: Renewed Selling Pressure Sends Stock to New 52-Week Low
The rally was short-lived as the stock plunged 5.38% to close at Rs.175.05, hitting a new 52-week low intraday at Rs.173.60. This decline significantly outpaced the Sensex’s 1.16% fall to 36,322.56. The stock underperformed its sector by over 5%, reflecting persistent negative sentiment. Technical analysis confirmed the stock trading below all key moving averages, reinforcing the bearish outlook. Financial results remained weak, with a quarterly net loss of Rs.12.97 crores and a low interest coverage ratio of 2.47 times. Institutional investors reduced their holdings by 0.51% in the previous quarter, signalling diminished confidence.
Is Dishman Carbogen Amcis Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Daily Price Comparison: Dishman Carbogen Amcis Ltd vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-02-23 | Rs.181.70 | -0.41% | 36,817.86 | +0.39% |
| 2026-02-24 | Rs.179.50 | -1.21% | 36,530.09 | -0.78% |
| 2026-02-25 | Rs.176.65 | -1.59% | 36,679.75 | +0.41% |
| 2026-02-26 | Rs.185.00 | +4.73% | 36,748.49 | +0.19% |
| 2026-02-27 | Rs.175.05 | -5.38% | 36,322.56 | -1.16% |
Key Takeaways
Persistent Downtrend: The stock experienced a five-day losing streak early in the week, hitting multiple 52-week lows and underperforming both the Sensex and its sector.
Short-Term Rebound: A sharp intraday rally on 26 February provided a temporary recovery, with the stock gaining 7.33%, but this was not sustained.
Weak Fundamentals: Financial metrics such as a low ROCE of 0.97%, high Debt to EBITDA ratio of 4.96, and a quarterly PAT loss of Rs.12.97 crores highlight ongoing operational challenges.
Institutional Caution: A reduction in institutional holdings by 0.51% signals diminished confidence from sophisticated investors.
Valuation Disconnect: Despite weak price performance, valuation metrics like a low PEG ratio of 0.1 suggest the stock trades at a discount relative to peers, though this has not translated into price support.
Conclusion
Dishman Carbogen Amcis Ltd’s share price volatility this week reflects a complex interplay of weak financial results, technical downtrends, and cautious investor sentiment. The stock’s 4.06% weekly decline significantly outpaced the Sensex’s 0.96% fall, underscoring its relative underperformance. While a brief rally on 26 February demonstrated potential for short-term recovery, the overall trend remains bearish, supported by a Strong Sell rating and low Mojo Score. Investors should note the persistent fundamental challenges and reduced institutional interest as key factors shaping the stock’s outlook in the near term.
Limited Period Only. Start at Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Get 71% Off →
